| 前收市價 | 0.3100 |
| 開市 | 無 |
| 買盤 | 0.0000 |
| 賣出價 | 4.1000 |
| 拍板 | 40.00 |
| 到期日 | 2024-05-17 |
| 今日波幅 | 0.3100 - 0.3100 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 3 |
InvestorPlace3 Underappreciated Stocks That Could 10x in 10 Years
Like achieving a hole-in-one, holding a tenbagger is one of the best results any investor could wish for. A term popularized by legendary investor Peter Lynch, these stocks are innovators with the potential to grow exponentially. Indeed, 10x stocks are market disrupters and innovators. And they create products people love. Today, I’m on the hunt for three potential 10x stocks to result in a home run. To come up with the list, I screened for the following criteria: Small-mid cap stocks ($300 mill
ZacksVerve Therapeutics (VERV) Reports Q1 Loss, Tops Revenue Estimates
Verve Therapeutics (VERV) delivered earnings and revenue surprises of 13.24% and 12.77%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ZacksWhy Investors Need to Take Advantage of These 2 Medical Stocks Now
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
